What causes rare myocarditis in young men after Covid vaccines?

AdobeAnewstudyshedslightonwhatmaybecausingveryrarecasesofheartinflammationinyoungmenafterreceivingan AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s




explore

author：focus    Page View：482
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： The haunting brain science of long Covid
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies